Elderly and infirm air passengers deserve better treatment says Joanna Symons.

The first human trials of a stem cell therapy for an eye disease that causes blindness in young people could start next year.

Britain's leading health and wellbeing specialists answer your question. This week: Crohn's disease.

Dr Hubley's is just the most serious in a growing list of cases which raise serious concerns about the safety of 'independent sector treatment centres' writes Andrew Gilligan.

Simon Maddrell quit a career in big business to found Excellent Development a charity that helps provide clean water to thousands of Kenyan farmers. Elizabeth Grice talks to him about his work.

If we are to escape from dilemmas such as Nice's fateful decision on Nexavar it can only be by permitting additional revenue streams into the NHS argues Janet Daley.

The difficult truth is that Nexavar is an expensive drug that extends life by on average less than three months writes Rebecca Smith.